Please login to the form below

Not currently logged in
Email:
Password:

Actilyse

This page shows the latest Actilyse news and features for those working in and with pharma, biotech and healthcare.

Daiichi Sankyo licenses clot-busting antibody

Daiichi Sankyo licenses clot-busting antibody

as Genentech/Boehringer Ingelheim's Activase/Actilyse (alteplase), but Translational Sciences believes there is significant room for improvement.

Latest news

  • NICE stroke guidance boost for Boehringer's Actilyse NICE stroke guidance boost for Boehringer's Actilyse

    NICE stroke guidance boost for Boehringer's Actilyse. Institute changes guidance on alteplase use. ... More people suffering a stroke in the UK should get treatment with Boehringer Ingelheim's thrombolytic drug Actilyse in the wake of new NICE

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics